About Pearsanta
Pearsanta is a company based in Richmond (United States) founded in 2023. It operates as a B2B and D2C. Pearsanta has completed 1 acquisition, including MDNA Life Sciences. Pearsanta offers products and services including AditxtScore and Diagnostic Solutions. Pearsanta operates in a competitive market with competitors including Curative, Pictor, Proof Diagnostics, Biolidics and FluroTech, among others.
- Headquarter Richmond, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Pearsanta, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pearsanta
Pearsanta offers a comprehensive portfolio of products and services, including AditxtScore and Diagnostic Solutions.
Diagnostic application for COVID-19 using personalized data insights.
Tools for biosample processing and actionable health monitoring services.
People of Pearsanta
Unlock access to complete
Unlock access to complete
Funding Insights of Pearsanta
Detailed funding history for Pearsanta
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pearsanta
Pearsanta has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MDNA Life Sciences.
Investment portfolio details for Pearsanta
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genomic and molecular diagnostics based on mitochondrial genome are provided.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Pearsanta
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Pearsanta
Detailed financials for Pearsanta
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pearsanta Comparisons
Peer comparison for Pearsanta
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pearsanta
Pearsanta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curative, Pictor, Proof Diagnostics, Biolidics and FluroTech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Curative is recognized for providing affordable employer-sponsored health insurance.
|
|
| Locked | Locked | Locked |
Immunodiagnostic products are developed via multiplexed assays.
|
|
| Locked | Locked | Locked |
CRISPR-based COVID-19 molecular testing devices are manufactured.
|
|
| Locked | Locked | Locked |
Cell enrichment systems are provided for cancer diagnosis and treatment.
|
|
| Locked | Locked | Locked |
Smart devices for in-house cannabis and hemp testing are provided.
|
|
| Locked | Locked | Locked |
Provider of at-home COVID and COVID/Flu tests
|
Detailed competitors of Pearsanta
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pearsanta
Complete news archive for Pearsanta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pearsanta
Pearsanta was founded in 2023.
Pearsanta is headquartered in Richmond, United States. It is registered at Richmond, Virginia, United States.
Pearsanta is a medical diagnostic company that develops personalized, data-driven solutions for healthcare, focusing on biosample collection, processing, and actionable insights based on patient demographics, genetics, and risk factors. It uses patented technology and a CLIA-certified monitoring center to deliver innovations like diagnostic tools for conditions such as COVID-19. Operating in the US, Pearsanta targets providers and patients to disrupt traditional healthcare with precise monitoring and insights, aiming for optimal health outcomes through diverse delivery channels.
Pearsanta offers AditxtScore and Diagnostic Solutions.
Pearsanta has made 1 acquisition, including MDNA Life Sciences.